Brady Todd C bought ALDX
March 27, 2026 · Form 4 insider transaction
Brady Todd C bought 1,880,510 shares of Aldeyra Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,880,510
Price
$0.00
Total value
N/A
InsiderBrady Todd C
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 27, 2026
Filing dateMarch 31, 2026
Shares owned after1,880,510
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2026.